Sutro Biopharma Hits Major Technical Milestone, Reaching 100 Liter Scale for the Company’s Open Cell-free Protein Synthesis Technology
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Sutro Biopharma, Inc., a pioneer in open cell-free synthesis for the discovery and production of proteins, announced today the first ever achievement of therapeutic protein production at 100 L scale using a cell-free synthesis technology.